Ocular Complications from Chemotherapeutic Agents
MEK inhibitors
- Selumetinib, Binimetinib, Trametinib, Cobimetinib
- Blurred vision, diplopia, eyelid edema, subconjunctival hemorrhage, increased lacrimation
- Retinal pigment epithelial detachment, Central serous-like retinopathy